Jonathan Allan

Insider Reports History

Location
Bedford, MA
Signature
/s/ Jonathan Allan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jonathan Allan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Stoke Therapeutics, Inc. GENERAL COUNSEL & CORP SEC Common Stock 11.8K $386K $32.61 08 Dec 2025 Direct
Stoke Therapeutics, Inc. GENERAL COUNSEL & CORP SEC Performance Stock Units 0 $72.4K $12.07 03 Dec 2025 Direct
Stoke Therapeutics, Inc. GENERAL COUNSEL & CORP SEC Restricted Stock Units 0 $28.8K $0.60 01 Dec 2025 Direct
Stoke Therapeutics, Inc. GENERAL COUNSEL & CORP SEC Employee Stock Option (Right to Buy) 72K 20 Mar 2025 Direct
Stoke Therapeutics, Inc. GENERAL COUNSEL & CORP SEC Stock Option (Right to Buy) 34.8K 03 Oct 2025 Direct

Insider Reports Filed by Jonathan Allan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
STOK Stoke Therapeutics, Inc. 08 Dec 2025 2 -$128K 4 GENERAL COUNSEL & CORP SEC 10 Dec 2025, 16:24
STOK Stoke Therapeutics, Inc. 03 Dec 2025 7 -$306K 4 GENERAL COUNSEL & CORP SEC 05 Dec 2025, 20:49
STOK Stoke Therapeutics, Inc. 01 Dec 2025 6 -$138K 4 GENERAL COUNSEL & CORP SEC 03 Dec 2025, 20:20
STOK Stoke Therapeutics, Inc. 03 Oct 2025 3 -$159K 4 GENERAL COUNSEL & CORP SEC 07 Oct 2025, 16:26
STOK Stoke Therapeutics, Inc. 29 Aug 2025 7 -$374K 4 GENERAL COUNSEL & CORP SEC 03 Sep 2025, 17:50
STOK Stoke Therapeutics, Inc. 18 Aug 2025 1 -$30.7K 4 GENERAL COUNSEL & CORP SEC 20 Aug 2025, 16:11
STOK Stoke Therapeutics, Inc. 14 Aug 2025 3 $0 4 GENERAL COUNSEL & CORP SEC 18 Aug 2025, 20:24
STOK Stoke Therapeutics, Inc. 13 Aug 2025 1 -$206K 4 GENERAL COUNSEL & CORP SEC 15 Aug 2025, 16:31
STOK Stoke Therapeutics, Inc. 18 Mar 2025 4 -$35.7K 4 GENERAL COUNSEL & CORP SEC 20 Mar 2025, 18:05
STOK Stoke Therapeutics, Inc. 15 Mar 2025 4 $0 4 GENERAL COUNSEL & CORP SEC 18 Mar 2025, 16:11
STOK Stoke Therapeutics, Inc. 09 Dec 2024 2 -$186K 4 GENERAL COUNSEL & CORP SEC 11 Dec 2024, 16:05
STOK Stoke Therapeutics, Inc. 06 Dec 2024 1 -$124K 4 GENERAL COUNSEL & CORP SEC 10 Dec 2024, 19:01
STOK Stoke Therapeutics, Inc. 03 Dec 2024 3 $0 4 GENERAL COUNSEL & CORP SEC 05 Dec 2024, 16:21
STOK Stoke Therapeutics, Inc. 01 Dec 2024 2 $0 4 GENERAL COUNSEL & CORP SEC 03 Dec 2024, 16:14
STOK Stoke Therapeutics, Inc. 20 May 2024 3 -$68.5K 4 GENERAL COUNSEL & CORP SEC 22 May 2024, 16:15
STOK Stoke Therapeutics, Inc. 28 Mar 2024 2 -$67.7K 4 GENERAL COUNSEL & CORP SEC 01 Apr 2024, 16:14
STOK Stoke Therapeutics, Inc. 27 Mar 2024 2 $0 4 GENERAL COUNSEL & CORP SEC 07 Jun 2024, 16:37
STOK Stoke Therapeutics, Inc. 15 Mar 2024 3 -$14.3K 4 GENERAL COUNSEL & CORP SEC 19 Mar 2024, 20:29
STOK Stoke Therapeutics, Inc. 01 Dec 2023 3 $0 4 General Counsel & Corp Sec 05 Dec 2023, 16:09
STOK Stoke Therapeutics, Inc. 21 Jun 2023 1 -$26.3K 4 General Counsel & Corp Sec 23 Jun 2023, 16:45
STOK Stoke Therapeutics, Inc. 15 Mar 2023 2 $0 4 General Counsel & Corp Sec 17 Mar 2023, 16:37
STOK Stoke Therapeutics, Inc. 15 Mar 2023 0 $0 3 General Counsel & Corp Sec 17 Mar 2023, 15:40